Avantor (NYSE:AVTR) Releases Quarterly Earnings Results, Beats Estimates By $0.01 EPS

by · The Cerbat Gem

Avantor (NYSE:AVTR – Get Free Report) announced its earnings results on Wednesday. The company reported $0.22 EPS for the quarter, beating analysts’ consensus estimates of $0.21 by $0.01, FiscalAI reports. The firm had revenue of $1.70 billion for the quarter, compared to analyst estimates of $1.64 billion. Avantor’s revenue was up 4.6% compared to the same quarter last year. During the same period in the previous year, the company earned $0.22 EPS.

Here are the key takeaways from Avantor’s conference call:

  • Avantor returned to organic revenue growth in Q3, with revenue up 5.2% organically to $1.698 billion. VWR grew 5.8%, while Bioscience & Medtech Products returned to growth at 3.6%, supported by improved execution and stronger demand.
  • Management raised its 2026 outlook, now expecting organic revenue growth of 0.75%–1.25%, adjusted EPS of $0.81–$0.83, and free cash flow of $525–$550 million. The company expects adjusted net leverage to fall below 3.0x by year-end, compared with 3.1x at the end of Q3.
  • The company cited continued momentum from its Revival program, including improved manufacturing throughput, supply-chain execution, customer service, e-commerce, and AI-enabled commercial tools. BMP also reported positive book-to-bill trends and strong performance in Process Chemicals and NuSil.
  • Profitability remains pressured by product and customer mix, inflation, and targeted growth investments, particularly in VWR. Management said 2026 pricing of roughly 1%–2% has not fully offset inflation, while Europe remains a weak market and BMP faces approximately 400 basis points of discrete comparison headwinds in Q4.

Avantor Price Performance

Avantor stock traded down $0.74 during mid-day trading on Wednesday, reaching $16.39. 10,506,330 shares of the company’s stock were exchanged, compared to its average volume of 10,117,616. Avantor has a twelve month low of $7.26 and a twelve month high of $17.45. The company has a fifty day moving average of $15.34 and a 200-day moving average of $11.18.

Analysts Set New Price Targets

Several equities research analysts recently commented on AVTR shares. TD Cowen increased their price target on Avantor from $15.00 to $17.00 and gave the company a “hold” rating in a report on Tuesday, October 13th. Wall Street Zen upgraded shares of Avantor from a “hold” rating to a “buy” rating in a report on Sunday, October 11th. Wolfe Research raised shares of Avantor from a “strong sell” rating to a “hold” rating in a research report on Thursday, July 30th. Royal Bank Of Canada increased their target price on shares of Avantor from $9.00 to $14.00 and gave the stock a “sector perform” rating in a research note on Thursday, July 30th. Finally, Stifel Nicolaus lifted their price target on shares of Avantor from $8.00 to $15.00 and gave the company a “hold” rating in a research report on Thursday, July 30th. One equities research analyst has rated the stock with a Buy rating, fifteen have assigned a Hold rating and one has issued a Sell rating to the company’s stock. Based on data from MarketBeat.com, the company has an average rating of “Hold” and a consensus price target of $13.06.

View Our Latest Analysis on Avantor

Avantor News Summary

Here are the key news stories impacting Avantor this week:

  • Positive Sentiment: Avantor reported net sales of $1.698 billion, up 4.6% year over year and ahead of the $1.64 billion consensus estimate. Organic sales increased 5.2%, indicating improving underlying demand across the business. Avantor Reports Third Quarter 2026 Results
  • Positive Sentiment: Adjusted earnings were $0.22 per share, exceeding the $0.21 analyst consensus and matching the prior-year result. Diluted GAAP EPS was $0.30. The revenue and earnings beats support the recent increase in AVTR’s share price and suggest execution is improving. Avantor Surpasses Q3 Earnings and Revenue Estimates
  • Positive Sentiment: Management raised its full-year 2026 organic revenue growth, adjusted EPS and free-cash-flow guidance after results exceeded expectations. Higher guidance is likely the most important bullish development for investors because it improves the outlook for future earnings and cash generation. Avantor Guidance Update
  • Neutral Sentiment: Avantor appointed Mikey Santiago as chief information officer to lead its global IT strategy. The change may support operational efficiency over time but is unlikely to materially affect near-term trading. Avantor Appoints New Chief Information Officer
  • Negative Sentiment: Barclays maintained a Sell rating and a $15 price target, below AVTR’s recent trading level. This signals that some analysts remain concerned about valuation or the durability of the recovery despite the upbeat quarter. Barclays Maintains Sell Rating on Avantor

Avantor Company Profile

(Get Free Report)

Avantor, Inc is a global provider of mission-critical products and services used in the life sciences, healthcare, education, and advanced technology industries. The company supplies chemicals, reagents, laboratory consumables, equipment, and other materials used in research, development, manufacturing, and quality-control activities.

Avantor also provides specialized solutions for biopharmaceutical production, including materials and services that support drug development, biologics manufacturing, and other bioprocessing applications.

See Also